Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.Dietrich C. Gulba, P. R. Lichtlen, W. Rafflenbeul et al.|Circulation|1991Cited by 173
Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group.P. R. Lichtlen, W. Rafflenbeul, Peter Nikutta et al.|Circulation|1992Cited by 119
Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)P. R. Lichtlen, Jaap W. Deckers, Paul G. Hugenholtz et al.|Cardiovascular Drugs and Therapy|1990Cited by 93
Comparison of different quantitative coronary analysis systems: ARTREK, CAAS, and CMSJörg Hausleiter, P. R. Lichtlen, Matthias Stürm et al.|Catheterization and Cardiovascular Diagnosis|1996Cited by 64